Skip to content
10-Q

Quarterly Report

HypGen Inc

0001662252-18-000008

← back to feed
Filed
Jan 8, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jan 5, 2018 135.8M sh
Capex Q2 2017 · Nov 30, 2017 $1.94K
Operating Cash Flow Q2 2017 · Nov 30, 2017 −$325.94K
Operating Cash Flow Q2 2017 · Nov 30, 2016 −$276
Stockholders Equity Q2 2017 · Nov 30, 2017 −$386.81K
Stockholders Equity Q2 2017 · May 31, 2017 −$192.91K
Total Liabilities Q2 2017 · Nov 30, 2017 $580.05K
Total Liabilities Q2 2017 · May 31, 2017 $215.08K
Current Assets Q2 2017 · Nov 30, 2017 $191.43K
Current Assets Q2 2017 · May 31, 2017 $22.17K
Total Assets Q2 2017 · Nov 30, 2017 $193.24K
Total Assets Q2 2017 · May 31, 2017 $22.17K
Sga Expense Q2 2017 · Nov 30, 2017 $55.62K
Sga Expense Q2 2017 · Nov 30, 2017 $305.38K
Sga Expense restated Q2 2017 · Nov 30, 2016 $1.65K
Sga Expense restated Q2 2017 · Nov 30, 2016 $19.4K
Rd Expense Q2 2017 · Nov 30, 2017 $0
Rd Expense Q2 2017 · Nov 30, 2016 $0
Net Income Q2 2017 · Nov 30, 2017 −$183.86K
Net Income Q2 2017 · Nov 30, 2017 −$537.48K
Net Income restated Q2 2017 · Nov 30, 2016 −$381
Net Income Q2 2017 · Nov 30, 2016 −$731
Operating Income Q2 2017 · Nov 30, 2017 −$158.69K
Operating Income Q2 2017 · Nov 30, 2017 −$500.47K
Operating Income Q2 2017 · Nov 30, 2016 −$1.65K
Operating Income Q2 2017 · Nov 30, 2016 −$19.4K